COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Lumicell, Inc.. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Nov 25, 2025 to Nov 25, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code SAW appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P230014, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 275 Washington St., Suite 200, Newton, MA, 02458. Recorded on P230014/S004, decision dated Nov 25, 2025.
Device categories in this collection
Fluorescence imaging for breast cancer detection.
Changes described in PMA records
FDA’s recorded scope: Approval for changes to the labeling including additional caution/warning/guidance statements and updated labeling to address corrective actions taken with respect to breaking or detachment of elastic bands from the device during use.
Nov 25, 2025 · Special (Immediate Track)Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.